A detailed history of Roffman Miller Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Roffman Miller Associates Inc holds 25,572 shares of PFE stock, worth $683,283. This represents 0.05% of its overall portfolio holdings.

Number of Shares
25,572
Previous 25,531 0.16%
Holding current value
$683,283
Previous $708,000 0.99%
% of portfolio
0.05%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$25.26 - $29.6 $1,035 - $1,213
41 Added 0.16%
25,572 $715,000
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $70,317 - $80,746
-2,716 Reduced 9.62%
25,531 $708,000
Q4 2023

Feb 02, 2024

SELL
$26.13 - $33.94 $5,461 - $7,093
-209 Reduced 0.73%
28,247 $813,000
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $33,469 - $39,122
1,043 Added 3.8%
28,456 $943,000
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $29,040 - $33,599
-804 Reduced 2.85%
27,413 $1.01 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $68,577 - $89,278
-1,741 Reduced 5.81%
28,217 $1.15 Million
Q4 2022

Jan 17, 2023

BUY
$41.75 - $54.5 $150,592 - $196,581
3,607 Added 13.69%
29,958 $0
Q3 2022

Nov 07, 2022

SELL
$43.76 - $53.42 $18,160 - $22,169
-415 Reduced 1.55%
26,351 $1.15 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $4,932 - $5,848
106 Added 0.4%
26,766 $1.4 Million
Q1 2022

May 24, 2022

SELL
$45.75 - $56.69 $3,980 - $4,932
-87 Reduced 0.33%
26,660 $1.38 Million
Q4 2021

Feb 03, 2022

SELL
$41.32 - $61.25 $6,569 - $9,738
-159 Reduced 0.59%
26,747 $1.58 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $44,823 - $57,579
1,142 Added 4.43%
26,906 $1.16 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $85,034 - $96,330
2,368 Added 10.12%
25,764 $1.01 Million
Q1 2021

Apr 16, 2021

BUY
$33.49 - $37.77 $73,041 - $82,376
2,181 Added 10.28%
23,396 $848,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $29,487 - $37,495
881 Added 4.33%
21,215 $781,000
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $265,080 - $311,000
-8,349 Reduced 29.11%
20,334 $746,000
Q2 2020

Nov 06, 2020

BUY
$30.12 - $36.54 $272,104 - $330,102
9,034 Added 45.98%
28,683 $889,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $125,743 - $179,660
-4,652 Reduced 19.14%
19,649 $641,000
Q4 2019

Jan 24, 2020

BUY
$32.92 - $37.36 $26,467 - $30,037
804 Added 3.42%
24,301 $952,000
Q3 2019

Nov 04, 2019

BUY
$32.49 - $42.13 $96,820 - $125,547
2,980 Added 14.52%
23,497 $844,000
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $22,003 - $24,704
595 Added 2.99%
20,517 $889,000
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $747,075 - $820,786
19,922 New
19,922 $846,000
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $650,835 - $742,023
-16,918 Closed
0 $0
Q3 2018

Nov 06, 2018

BUY
$34.47 - $41.81 $19,165 - $23,246
556 Added 3.4%
16,918 $746,000
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $64,772 - $69,054
1,964 Added 13.64%
16,362 $594,000
Q1 2018

May 01, 2018

SELL
$31.91 - $37.02 $16,146 - $18,732
-506 Reduced 3.4%
14,398 $511,000
Q4 2017

Feb 06, 2018

BUY
$33.26 - $35.29 $22,350 - $23,714
672 Added 4.72%
14,904 $540,000
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $441,192 - $486,022
14,232
14,232 $508,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Roffman Miller Associates Inc Portfolio

Follow Roffman Miller Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roffman Miller Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roffman Miller Associates Inc with notifications on news.